Quantum biopharma receives nasdaq notification of regaining compliance with nasdaq's minimum bid price requirement and completes debt settlements

Toronto, on / accesswire / september 6, 2024 / quantum biopharma ltd. (formerly, fsd pharma inc.) (nasdaq:qntm)(cse:qntm)(fra:0k91) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it has received a formal notice from the nasdaq stock market, llc ("nasdaq") stating that the company has regained compliance with the minimum bid price requirement set forth in rule 5550(a)(2) of the nasdaq listing rules.
QNTM Ratings Summary
QNTM Quant Ranking